Alaunos Therapeutics | Betriebsaufwand



Operating Expenses Veränderung Datum
Adcock Ingram Holdings ZAR 4.42B 268.95M 2024-06
Alaunos Therapeutics USD 1.15M 20K 2024-09
Amgen USD 6.78B 401M 2024-12
AstraZeneca USD 12.86B 2.06B 2024-12
Baxter International USD 3.19B 644M 2024-12
Biogen USD 2.01B 13.3M 2024-12
Bioline Rx USD 10.33M 836K 2024-09
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Celltrion KRW 674.25B 128.01B 2024-09
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Cspc Pharmaceutical CNY 5.42B 102.74M 2024-09
Dianthus Therapeutics USD 32.07M 8M 2024-09
Ecofibre AUD 12.31M 44.07M 2024-06
Gilead Sciences USD 5.12B 1.54B 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
Incyte USD 877.18M 114.6M 2024-12
Ionis Pharmaceuticals USD 337.4M 54.93M 2024-12
J&J USD 18.63B 500M 2024-12
Kangmei Pharma CNY 1.46B 193.63M 2024-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 141M 9.11M 2024-06
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 10.35M 17.73M 2024-06
Merck USD 11.33B 1.4B 2024-12
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Novartis USD 11.28B 1.73B 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Pharma Mar EUR 43.47M 3.3M 2024-12
PTC Therapeutics USD 275.66M 24.36M 2024-12
Qiagen NV USD 377.04M 4.6M 2024-12
Regeneron Pharmaceuticals USD 2.8B 26.53B 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Sartorius EUR 725.4M 29M 2024-09
Sino Biopharmaceutical CNY 6.2B 2.04B 2024-06
TG Therapeutics USD 78.24M 6.79M 2024-12
Tilray USD 253.17M 16.55M 2024-11
Zz Pientze Pharmaceu 1.67B 86.7M 2024-09



Alaunos Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.